Global Epilepsy Drugs Market: COVID-19 Impact Analysis| Forecasting Strategies for New Normal | Technavio

·4 min read

The epilepsy drugs market is poised to grow by USD 2.13 billion during 2020-2024, progressing at a CAGR of over 5% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201126005514/en/

Technavio has announced its latest market research report titled Global Epilepsy Drugs Market 2020-2024 (Graphic: Business Wire)

Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Get FREE Sample Report in Minutes!

The report on the epilepsy drugs market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the increasing prevalence of epilepsy.

The epilepsy drugs market analysis includes type, etiology, age of onset, and geography landscape. This study identifies the growing use of specific and sensitive diagnostic modalities as one of the prime reasons driving the epilepsy drugs market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The epilepsy drugs market covers the following areas:

Epilepsy Drugs Market Sizing

Epilepsy Drugs Market Forecast

Epilepsy Drugs Market Analysis

Companies Mentioned

  • Abbott Laboratories

  • Eisai Co. Ltd.

  • GlaxoSmithKline Plc

  • Johnson & Johnson

  • Mylan NV

  • Novartis AG

  • Pfizer Inc.

  • Sanofi

  • Teva Pharmaceutical Industries Ltd.

  • UCB SA

Related Reports on Health Care Include:

Global Lifestyle Drugs Market - Global lifestyle drugs market is segmented by therapy area (depression, dermatology, sexual dysfunction, and obesity) and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report

Global Antifungal Drugs Market - Global antifungal drugs market is segmented by route of administration (topical, oral, and parenteral) and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem

  • Market characteristics

  • Value chain analysis

Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2019

  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

Market Segmentation by Type

  • Market segments

  • Comparison by Type

  • Narrow spectrum drugs - Market size and forecast 2019-2024

  • Broad spectrum drugs - Market size and forecast 2019-2024

  • Market opportunity by Type

Segmentation by Etiology

  • Genetic etiology

  • Structural etiology

  • Metabolic etiology

  • Immune etiology

  • Infectious etiology

  • Unknown etiology

Segmentation by Age of Onset

  • Neonatal/infantile

  • Childhood

  • Adolescents/adults

  • Variable age

Customer landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2019-2024

  • Europe - Market size and forecast 2019-2024

  • Asia - Market size and forecast 2019-2024

  • ROW - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity by geography

  • Market drivers

  • Market challenges

  • Market trends

Vendor Landscape

  • Vendor landscape

  • Landscape disruption

  • Competitive Scenario

Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Abbott Laboratories

  • Eisai Co. Ltd.

  • GlaxoSmithKline Plc

  • Johnson & Johnson

  • Mylan NV

  • Novartis AG

  • Pfizer Inc.

  • Sanofi

  • Teva Pharmaceutical Industries Ltd.

  • UCB SA

Appendix

  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201126005514/en/

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/